ALNY reports better-than-expected fourth-quarter results as both earnings and revenues beat estimates driven by higher ...
Alnylam Pharmaceuticals exceeded Wall Street's expectations with strong revenue growth and significant commercial progress.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback